Ticker
EU Commission secures 500,000 Remdesivir doses
By EUobserver
The European Commission signed on Thursday a €70m joint-procurement contract with the pharmaceutical firm Gilead for the supply of up to 500,000 doses of Remdesivir - the only medicine with a marketing authorisation in the EU for the treatment of Covid-19 patients needing oxygen. All EU and EEA countries, the UK, as well as six candidate and potential candidate countries are participating in this joint procurement.